_edited_edited_edite.png)
Bioidentical Hormone Replacement Therapy (BHRT) in Naples & Marco Island
If you have been researching bioidentical hormone replacement therapy — or your symptoms have brought you to the point of looking for a specialist who prescribes BHRT — this page is meant to be a clear, evidence-based guide. We explain what bioidentical hormones actually are, how the terminology has been confused, what the FDA-approved bioidentical options are, where compounded BHRT has a role and where it does not, and how a thoughtful BHRT consultation actually works.
What bioidentical hormones actually are.
A bioidentical hormone is one with a molecular structure identical to the hormone the human body produces. Bioidentical estradiol is the exact same molecule as the estradiol your ovaries made in your twenties. Bioidentical progesterone is the exact same molecule as the progesterone your ovaries made in the second half of your cycle. Bioidentical testosterone is the exact same molecule as the testosterone produced by ovaries, adrenal glands, and (in men) testes. This is in contrast to non-bioidentical hormones — synthetic progestins (like medroxyprogesterone acetate) and conjugated equine estrogens (Premarin, derived from pregnant mare urine) — which have different molecular structures and somewhat different receptor effects. Bioidentical hormones can be FDA-approved (mass-produced and rigorously tested) or compounded (custom-made by a compounding pharmacy). This distinction matters and is a source of confusion in the public conversation.
Progesterone
The terminology confusion.
The term 'BHRT' is used loosely in marketing and in lay media, sometimes implying that compounded bioidentical hormones are inherently superior, more 'natural,' or safer than FDA-approved bioidentical hormones. This is not supported by evidence. The molecule is what matters — and FDA-approved bioidentical estradiol patches, bioidentical estradiol gels, micronized progesterone capsules, and bioidentical vaginal estrogen are all evidence-based, well-studied, and excellent options. Compounded bioidentical hormones (sometimes called cBHT — compounded bioidentical hormone therapy) have a more specific role: they can be useful for patients who need a dose, ratio, or delivery form not available in an FDA-approved product. For most patients, an FDA-approved bioidentical option is appropriate and preferred. Compounded options are added when there is a specific clinical reason.
Who BHRT helps.
BHRT is appropriate for women in perimenopause and menopause with symptoms that meaningfully affect quality of life — vasomotor symptoms, sleep disruption, mood changes, genitourinary symptoms, cognitive symptoms, and decreased libido. It is also appropriate in selected younger women with premature ovarian insufficiency, after surgical menopause, and for genitourinary syndrome of menopause at any age. For men, BHRT (specifically testosterone replacement therapy) is appropriate in those with documented low testosterone and consistent symptoms (fatigue, low libido, decreased muscle mass, mood changes, loss of motivation) after appropriate evaluation.
Common BHRT forms and routes.
Bioidentical hormones can be delivered through several routes. The choice depends on the hormone, the indication, the patient's preferences, and safety considerations.
Transdermal Estradiol
Patch, gel, spray
-
Most preferred route for systemic estrogen
-
Avoids first-pass hepatic metabolism
-
Favorable risk profile compared to oral estrogen
-
Particularly lower risk of venous thromboembolism (VTE)
-
Forms available: patch, gel, spray
Vaginal Estrogen
Cream, tablet, or ring
-
For genitourinary symptoms (vaginal dryness, painful intercourse, recurrent UTIs)
-
Minimal systemic absorption
-
Appropriate for most women — including many with a history of breast cancer*
-
*In consultation with the patient's oncologist
-
Oral Micronized Progesterone
-
Required for women with an intact uterus (with systemic estrogen)
-
Protects the endometrium from unopposed estrogen
-
Bonus: sleep-supportive effect
-
Frequently used during perimenopause for both functions
Testosterone in Women
Compounded cream or pellet
-
Indications: low libido, low energy (in appropriate clinical context)
-
Minimal systemic absorption
-
Routes available:
-
Compounded cream
-
Pellet
-
Safety considerations — current evidence.
Hormone therapy is safer than the post-WHI conventional wisdom suggested. The Women's Health Initiative (WHI), published in 2002, was widely interpreted to mean that hormone therapy was harmful. Subsequent re-analyses have established that the original WHI population was older than typical hormone therapy candidates, and that the risk-benefit profile for younger women (within ten years of menopause, under age sixty) is substantially more favorable — and in many cases includes cardiovascular benefit. Risk is individualized. Personal and family history of breast cancer, history of venous thromboembolism, cardiovascular risk profile, and a few other factors shape the appropriate plan. A thoughtful consultation builds a treatment plan with these considerations explicitly addressed, not generically.
How a BHRT consultation works.
The consultation begins with a careful history — symptoms, timeline, prior treatment attempts, family history, personal medical history, and treatment goals. The exam is focused on relevant findings. Laboratory testing is selective — comprehensive metabolic panel, lipid profile, thyroid function, hormone levels in some contexts (more useful for testosterone than for estradiol/FSH in perimenopause), and screening tests as appropriate. The plan is built together, with discussion of forms, doses, expected timeline of response, monitoring, and adjustment. Follow-up is typically at six to eight weeks to assess response and refine. Before considering BHRT, many of our patients have been told their hormones are "fine" or that their symptoms are not worth treating. Read more on why perimenopause is so often missed →
Realistic expectations.
Most patients see meaningful improvement in symptoms within a few weeks of starting hormone therapy, with continued refinement over the first few months. Symptom relief is the primary metric — labs are a tool, not the goal. Treatment is typically continued as long as the benefit outweighs any risk and the patient wants to continue. There is no fixed time limit on hormone therapy; the decision is individualized and revisited periodically.
Our approach.
At Timeless Interventional of Naples, Dr. Chaturani Ranasinghe, MD, provides specialist-level BHRT consultation alongside her work in pelvic and interventional pain. The approach is evidence-based, individualized, and built around your specific symptoms, risk profile, and treatment preferences.
Schedule a consultation
Call to schedule a consultation or book online.
Dr. Ranasinghe is a certified EVEXIAS-trained provider, part of a national network of physicians specializing in bioidentical hormone therapy
